Janney Montgomery Scott LLC Immuno Gen, Inc. Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$4.48 - $6.47 $4,583 - $6,618	1,023 Added 2.48%	42,326 $202,000
Q2 2022 Aug 03, 2022	SELL	$3.15 - $5.76 $21,215 - $38,793	-6,735 Reduced 14.02%	41,303 $186,000
Q1 2022 May 04, 2022	SELL	$4.26 - $7.48 $43,371 - $76,153	-10,181 Reduced 17.49%	48,038 $229,000
Q4 2021 Jan 27, 2022	BUY	$4.75 - $7.5 $54,330 - $85,785	11,438 Added 24.45%	58,219 $432,000
Q3 2021 Oct 29, 2021	SELL	$5.02 - $6.59 $20,386 - $26,761	-4,061 Reduced 7.99%	46,781 $265,000
Q2 2021 Jul 26, 2021	BUY	$5.79 - $8.6 $3,647 - $5,418	630 Added 1.25%	50,842 $335,000
Q1 2021 Apr 27, 2021	SELL	$6.5 - $10.53 $3,731 - $6,044	-574 Reduced 1.13%	50,212 $407,000
Q4 2020 Jan 25, 2021	SELL	$3.7 - $7.66 $11,425 - $23,654	-3,088 Reduced 5.73%	50,786 $328,000
Q3 2020 Nov 06, 2020	SELL	$3.45 - $4.89 $72 - $102	-21 Reduced 0.04%	53,874 $194,000
Q2 2020 Jul 23, 2020	SELL	$3.32 - $5.34 $11,683 - $18,791	-3,519 Reduced 6.13%	53,895 $248,000
Q1 2020 Apr 30, 2020	SELL	$2.12 - $6.8 $7,780 - $24,956	-3,670 Reduced 6.01%	57,414 $196,000
Q4 2019 Jan 21, 2020	SELL	$2.25 - $5.8 $3,741 - $9,645	-1,663 Reduced 2.65%	61,084 $312,000
Q3 2019 Oct 29, 2019	SELL	$2.22 - $3.39 $30,140 - $46,026	-13,577 Reduced 17.79%	62,747 $152,000
Q2 2019 Jul 29, 2019	BUY	$1.8 - $3.3 $264 - $485	147 Added 0.19%	76,324 $166,000
Q1 2019 Apr 30, 2019	SELL	$2.41 - $5.91 $4,121 - $10,106	-1,710 Reduced 2.2%	76,177 $206,000
Q4 2018 Feb 01, 2019	SELL	$3.94 - $9.7 $33,588 - $82,692	-8,525 Reduced 9.87%	77,887 $374,000
Q3 2018 Nov 05, 2018	BUY	$8.6 - $11.26 $15,781 - $20,662	1,835 Added 2.17%	86,412 $818,000
Q2 2018 Jul 24, 2018	BUY	$9.52 - $12.15 $45,686 - $58,307	4,799 Added 6.02%	84,577 $823,000
Q1 2018 Apr 19, 2018	BUY	$6.7 - $12.95 $34,096 - $65,902	5,089 Added 6.81%	79,778 $839,000
Q4 2017 Feb 14, 2018	BUY	$5.07 - $7.92 $87,457 - $136,620	17,250 Added 30.03%	74,689 $479,000
Q3 2017 Nov 15, 2017	BUY	$5.4 - $8.47 $310,170 - $486,508	57,439	57,439 $439,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account